News Why non-diabetics using CGM may not be a good idea A clinical trial has found that a continuous glucose monitor device systemically overestimated blood glucose levels when used by non-diabetic people.
News Rishi Sunak becomes prostate cancer ambassador Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for its campaign for a national screening programme.
News Lilly launches discounted high-strength Zepbound vials in US Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.
News AI tool detects brain lesions linked to epilepsy Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.
News Kennedy delays first vaccine expert meeting under his watch Less than a week into the tenure of Robert F Kennedy Jr as HHS secretary, there are more signals that US immunisation is going to be shaken up.
News NICE changes its mind on BMS' lymphoma cell therapy Around 600 people with various types of B-cell lymphoma will be eligible for treatment with BMS' CAR-T therapy Breyanzi under new NICE guidance.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.